The Visual Freedom You Deserve

Treat short-sightedness with our innovative Implantable Collamer® Lens.

Made From Collamer®, a Collagen Co-Polymer

Proprietary to STAAR Surgical, Collamer® is biocompatible, stable and flexible, enabling minimally invasive insertion and encouraging harmony with your natural eye.

Soft & Pliable

EVO ICLs are easy to implant in the eye because of the soft and flexible structure. You won’t even know it’s there other than the fact that you have great vision.

See The Difference EVO Can Make

Life is about experiences, so make a change today and start taking in all that it has to offer.

Find a Doctor
Eye glasses top

Wide Range of Treatment

Contact lenses and glasses can be a hassle and limiting. EVO can treat a wide range of prescriptions, from -0.5D to -20D.

About EVO ICL

EVO can help you achieve sharp, clear vision that gives you the freedom to see the world without glasses or contacts. EVO, also known as the Implantable Collamer® Lens, is a type of refractive procedure to help correct the most common visual problem, myopia.

EVO vs LASIK vs PRK

When it comes to vision correction, deciding what’s best for your eyes can be difficult. Learn about the differences between procedures and see if EVO is the right fit for you.

ICL

Lasik

PRK

EVO

LASIK

PRK

Sharp and Clear Vision²

EVO

LASIK

PRK

20-30 Minute Outpatient Procedure

No Corneal Tissue Removed

Does Not Contribute to “Dry eye Syndrome”

EVO

LASIK

PRK

Removable or Reversible

Flexibility for Future Procedures

Treats Thin Corneas⁵

UV Protection

Long Term History

It Only Takes 30 Minutes

The EVO procedure is minimally invasive and the lens is implanted through a small opening allowing for a quick procedure and recovery time. With over 1,000,000 lenses implanted worldwide, EVO is quickly becoming a vision correction procedure of choice for many people around the world

Real Life Stories From Real Life Patients

The thing that I love about ICLs is that they are putting a lens in there that can be removed.

Jennifer Puno, Web Designer

I feel like a big part of health is using what your body already has. ICLs is in line with that because it’s keeping your eye completely intact. My eye is still my eye.

Eve Torres Gracie, Jiu Jitsu Instructor

I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmers market.

Sara Tso, Chef

There’s a few big road blocks to having glasses and being a photographer. Now I’ve got ICLs and I can run out and live my life unhindered.

Andrew Oxenham, Photographer

I had my first opportunity to put my ICLs eyes to the test recently in the Amazon rainforest, and it couldn't have been more exciting to be able to spot rare species better than ever.

Phil Torres, Entomologist, TV Show Host

Ready to Discover Visual Freedom With EVO? Find a Doctor Today

Important Safety Information

It is important to consider that EVO Visian® Implantable Collamer Lenses (ICL) are approved by the local health authority, which means they have been determined to be safe and effective. As with any procedure, there are risks to consider. If you have any questions or concerns it is always best to speak with a certified EVO Visian® Implantable Collamer Lens (ICL) doctor. The EVO Visian ICL family of lenses include EVO Visian ICL, EVO Visian Toric ICL, EVO+ Visian ICL, and EVO+ Visian Toric ICL and are designed for the correction/reduction of low to high myopia (-0.5 to -20.0 diopters (D)) and the correction/reduction of myopia in patients with up to -20 D of myopia with less than or equal to 6.0 D of astigmatism. The EVO Visian ICL family is indicated for use in phakic eye treatment and for: The correction/reduction of myopia in adults 21 – 60 years of age with power ranging from -0.5 D to -20.0 D at the spectacle plane. With an anterior chamber depth (ACD) equal to or greater than 3.0 mm, as measured from the corneal endothelium to the anterior lens capsule. This extended age range covering over 45 to 60 years of age only applies to the myopic EVO Visian ICL family, and only in countries covered by the jurisdiction of the EU Notified Bodies where the CE Mark is recognised (i.e., the EU, EEA, and EFTA). The EVO Visian ICL family of products currently in inventory do not have the updated Directions For Use (DFU) with this new wording yet, but it will be incorporated over time. EVO Visian ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO Visian ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. The EVO Visian Toric ICL is intended to correct or reduce astigmatism (up to 6.0 D) you may have (the EVO Visian ICL is not intended to treat your astigmatism). Implantation of an EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, Visian ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.

References

Find a Doctor

References

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council